Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
23/5 13:50
Biopharmaceutical stocks require time and patience. But when the company gets it right, investors get rewarded as they have with Kiniksa Pharmaceuticals (NASDAQ: KNSA). The stock is up over 100% in the last year. Much of that growth came after the company’s strong Q1 earnings re...